Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial

NCT00689611 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
392
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mark Eisenberg

Collaborators